Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 5/2017

01-05-2017 | Erratum

Erratum to: Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells

Authors: Masaki Iwasa, Yasuo Miura, Aya Fujishiro, Sumie Fujii, Noriko Sugino, Satoshi Yoshioka, Asumi Yokota, Terutoshi Hishita, Hideyo Hirai, Akira Andoh, Tatsuo Ichinohe, Taira Maekawa

Published in: International Journal of Hematology | Issue 5/2017

Login to get access

Excerpt

Owing to an unfortunate mistake at the typesetter’s end, Fig. 2 was published with errors which are corrected in this Erratum and in the original article. https://static-content.springer.com/image/art%3A10.1007%2Fs12185-017-2182-8/MediaObjects/12185_2017_2182_Fig2_HTML.gif …
Metadata
Title
Erratum to: Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells
Authors
Masaki Iwasa
Yasuo Miura
Aya Fujishiro
Sumie Fujii
Noriko Sugino
Satoshi Yoshioka
Asumi Yokota
Terutoshi Hishita
Hideyo Hirai
Akira Andoh
Tatsuo Ichinohe
Taira Maekawa
Publication date
01-05-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2182-8

Other articles of this Issue 5/2017

International Journal of Hematology 5/2017 Go to the issue

Letter to the Editor

Refractory ITP in a patient with Kabuki syndrome: response to low-dose rituximab

Original Article

Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia

Original Article

Detection of chromosomal abnormalities by G-banding and prognostic impact in follicular lymphoma in the rituximab era

Original Article

Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum

Case Report

5q− syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10)

Images in Hematology

Primary cutaneous plasmacytoma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits